BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Byrne CJ, Radley A, Inglis SK, Beer L, Palmer N, Duc Pham M, Allardice K, Wang H, Robinson E, Hermansson M, Semizarov D, Healy B, Doyle JS, Dillon JF. Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial. Aliment Pharmacol Ther 2022;55:1512-23. [PMID: 35538396 DOI: 10.1111/apt.16953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Robinson E, Byrne CJ, Carberry J, Radley A, Beer LJ, Inglis SK, Tait J, Macpherson I, Goldberg D, Hutchinson SJ, Hickman M, Dillon JF. Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts. BMC Public Health 2023;23:54. [PMID: 36611156 DOI: 10.1186/s12889-022-14911-1] [Reference Citation Analysis]
2 Maria Passos-castilho A, Tejna Persaud Udhesister S, Fontaine G, Jeong D, Dickie M, Lund C, Russell R, Kronfli N, on behalf of the Canadian Network on Hepatitis C (CanHepC). The 11th Canadian Symposium on Hepatitis C Virus: ‘Getting back on track towards hepatitis C elimination’. Canadian Liver Journal 2022. [DOI: 10.3138/canlivj-2022-0034] [Reference Citation Analysis]